Can one-stop cancer screening boost early detection in high-risk women?
NCT ID NCT07228000
First seen Nov 14, 2025 · Last updated Jun 17, 2026 · Updated 26 times
Summary
This study aims to see if offering combined breast and colon cancer screening navigation, along with genetic risk assessment, helps more Black and Hispanic women aged 45-74 get screened. Participants will be assigned to either bundled multi-cancer navigation or single-cancer navigation, and some will also receive pre-test genetic education. The goal is to find out which approach works best and for whom.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER SCREENING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ChristianaCare-Helen F. Graham Cancer Center & Research Institute
RECRUITINGNewark, Delaware, 19713, United States
Contact Email: •••••@•••••
-
Georgetown University
RECRUITINGWashington D.C., District of Columbia, 20007, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.